Literature DB >> 16794530

Urine cytokines profile in renal transplant patients with asymptomatic bacteriuria.

Michał Ciszek1, Leszek Paczek, Irena Bartłomiejczyk, Krzysztof Mucha.   

Abstract

BACKGROUND: The role of asymptomatic bacteriuria in kidney transplant recipients is unknown. There is no clear evidence of its effect on transplanted kidney.
METHODS: We studied urine cytokines profile among kidney transplant recipients with bacteriuria found in screening examination. Urine cultures were collected in 269 patients with stable graft function and serum creatinine level <2 mg/dl, during their routine visits. Interleukin (IL)-6 and IL-8 levels were measured in urine samples from patients with asymptomatic bacteriuria, symptomatic urinary tract infection and patients without bacteriuria (control group). Changes in serum creatinine level in patients with asymptomatic bacteriuria and in the control group were observed during 12 months follow up.
RESULTS: Urinary tract infection (UTI) was diagnosed in five patients and asymptomatic bacteriuria in 22 patients. Urine IL-6 level was significantly higher in symptomatic UTI group (median 15.71 pg/mg) but there were no differences between group of patients with asymptomatic bacteriuria (3.92 pg/mg) and control group (2.54 pg/mg). Urine IL-8 level was higher in symptomatic UTI group (median 146.8 pg/mg) and was also significantly higher in asymptomatic bacteriuria group (33.49 pg/mg) in comparison to control group (2.97 pg/mg; P=0.0002). During 1-year follow up, incidence of UTI was higher in the asymptomatic bacteriuria group than in the control group but graft function was not different in both groups.
CONCLUSIONS: Elevated urine IL-8 level in kidney transplant patients with asymptomatic bacteriuria may reflect impaired immune response to bacterial infection and occult inflammatory process in urinary tract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794530     DOI: 10.1097/01.tp.0000226072.20185.f8

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

Review 1.  UTI in kidney transplant.

Authors:  Daniel Ness; Jonathon Olsburgh
Journal:  World J Urol       Date:  2019-04-01       Impact factor: 4.226

2.  Recurrent urinary tract infections in kidney transplant recipients during the first-year influence long-term graft function: a single-center retrospective cohort study.

Authors:  Francesco Pesce; Marida Martino; Marco Fiorentino; Tiziana Rollo; Simona Simone; Pasquale Gallo; Giovanni Stallone; Giuseppe Grandaliano; Antonio Schena; Marcella Margiotta; Donata Mininni; Rita Palieri; Giuseppe Lucarelli; Michele Battaglia; Loreto Gesualdo; Giuseppe Castellano
Journal:  J Nephrol       Date:  2019-01-30       Impact factor: 3.902

3.  Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice.

Authors:  Abhijit S Naik; Vikas R Dharnidharka; Mark A Schnitzler; Daniel C Brennan; Dorry L Segev; David Axelrod; Huiling Xiao; Lauren Kucirka; Jiajing Chen; Krista L Lentine
Journal:  Transpl Int       Date:  2015-12-09       Impact factor: 3.782

4.  Genetic control of the variable innate immune response to asymptomatic bacteriuria.

Authors:  Jenny Grönberg-Hernández; Jenny Grönberg Hernández; Fredrik Sundén; John Connolly; Catharina Svanborg; Björn Wullt
Journal:  PLoS One       Date:  2011-11-28       Impact factor: 3.240

5.  Antibiotic Treatment Versus No Treatment for Asymptomatic Bacteriuria in Kidney Transplant Recipients: A Multicenter Randomized Trial.

Authors:  Núria Sabé; Isabel Oriol; Edoardo Melilli; Anna Manonelles; Oriol Bestard; Carolina Polo; Ibai Los Arcos; Manel Perelló; Dolors Garcia; Lluís Riera; Cristian Tebé; Òscar Len; Francesc Moreso; Josep M Cruzado; Jordi Carratalà
Journal:  Open Forum Infect Dis       Date:  2019-05-21       Impact factor: 3.835

6.  Bacterial urinary tract infection among adult renal transplant recipients at St. Paul's hospital millennium medical college, Addis Ababa, Ethiopia.

Authors:  Teklehaimanot Kiros; Daniel Asrat; Zeleke Ayenew; Estifanos Tsige
Journal:  BMC Nephrol       Date:  2019-07-31       Impact factor: 2.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.